Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Nearly 1 in 3 cancer surgeries leave cells behind, doubling the rate that cancer returns. InSyte Bio’s mission is to eliminate the recurrence by ensuring removal of all cancer cells during surgery by redesigning intraoperative surgical navigation with novel approaches to imaging, computer vision, and AI assisted surgical guidance.
At InSyte Bio, our vision is to fundamentally transform cancer surgery using molecular guidance. Our technology solves the persistence of leaving residual cancer cells behind because they cannot be seen or felt, and ensure removal of all cancer cells in a single operation.
With over a decade of experience in developing new imaging technologies at the worlds leading universities, a proven, novel imaging platform supported by prestigious awards from the NIH and DOD, and multiple patents and publications, we are poised to transform cancer surgery.
We have fundamentally re-invented the optical interface for intraoperative imaging, ushering in a new era of ultra-precise surgical navigation so that no cell is left behind. We have developed a surgical imaging system that can detect cancer cells 10,000 times more precisely than existing solutions in real-time, during surgery, enabling surgeons and oncologists to effectively combat the spread of cancer. Unlike any other technology available, InSyte’s approach not only enables orders of magnitude more precision, but also enables imaging at the tissue surface and deep in tissue, where the earliest signs of cancer spread in lymph nodes can hide.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.